With the rising trend of GLP-1 weight loss medications, there have been concerns about whether surgical options like lap bands, gastric sleeves, and bypass surgeries will become less popular.
Carney Wilson, a member of the band Wilson Phillips, recently opened up about her daunting experience on social media regarding the removal of her laparoscopic lap band. Previously, she had gastric bypass surgery in 2012 and later opted for the lap band, which is a silicone device placed around part of the stomach to help limit food intake.
In a candid Instagram post, Wilson, now 57, shared her struggles after being readmitted to the hospital due to complications from the lap band removal. She mentioned dealing with high blood pressure and swelling, saying, “It was intense. They found an ulcer. All the stress this year is no surprise. They actually discovered food buildup in the band.”
Earlier, in an interview, Wilson expressed her apprehension towards medications like Ozempic, calling them “scary.”
Understanding Weight Loss Surgery
A recent study published in the Journal of the American Medical Association indicated that bariatric surgery often leads to greater weight loss and reduced long-term costs compared to GLP-1 treatments.
Dr. Hector Perez, who specializes in guiding patients through obesity surgeries, noted that gastric bypass is particularly effective for conditions like diabetes and acid reflux, while gastric sleeve procedures are simpler and quite effective. He highlighted that patients typically lose between 25-35% of their body weight from these surgeries, enjoying prolonged effects.
While GLP-1 drugs, like Wegovy and Zepbound, can facilitate weight loss of approximately 15-22%, Dr. Perez emphasized that they require ongoing use to be effective, unlike surgical options that can provide lasting transformations without the need for continuous injections.
Dr. Marina Kurian, another obesity surgeon, emphasized the necessity of a spectrum of treatments for obesity, stressing that it’s not solely about willpower but a complex condition that can lead to repeated weight gain despite efforts to manage it.
Concerns Related to Procedures
Dr. Perez pointed out that lap bands have a reputation for causing long-term complications, suggesting they may be outdated in today’s medical landscape. He stated, “I spend more time removing them than actually implementing them.”
Although complications can arise from any surgery, especially long after the fact, most patients tend to do well, according to Dr. Clean, another expert in the field.
Kurian observed a decline in weight-loss surgeries attributed to the increasing popularity of GLP-1 medications but acknowledged that decisions are often influenced by factors like costs and insurance coverage.
Weight Loss Surgery Isn’t a “Free Pass”
For those considering weight loss surgery, Dr. Perez cautioned that it isn’t a simple solution; maintaining results requires a commitment to a healthy lifestyle. He underscored the importance of protein-focused diets and exercise, alongside routine vitamins and monitoring any potential side effects like reflux.
He advised tailoring procedures to each patient’s specific history and needs, highlighting that a balanced strategy between medication and surgery is essential for effective treatment.
Defending GLP-1 Medications
Dr. Brett Osborne pointed out potential risks associated with bariatric surgery, noting that it doesn’t inherently teach discipline or guarantee behavioral change. He remarked, “Surgery constricts your stomach, but the will to adhere to a postoperative diet is often lacking.”
On the other hand, he expressed that GLP-1 medications can fundamentally alter hunger and satisfaction levels, thus reshaping eating behaviors and offering more than just physical changes. They may also provide additional health perks, such as reducing the risk of dementia and heart disease.
While acknowledging that these medications are costly and may involve gastrointestinal side effects, Dr. Osborne reassured that proper medical supervision can help manage potential issues.
A representative from a pharmaceutical company noted that GLP-1 drugs symbolize significant progress in treating obesity, underscoring that both surgical and non-surgical options are crucial for effectively addressing this chronic issue.
